HilleVax, Inc. Common Stock
HLVX
HLVX: HilleVax Inc is a clinical-stage biopharmaceutical company. It is focused on developing and commercializing novel vaccines. The firm's initial program, HIL-214, is a virus-like particle (VLP) based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis (AGE) caused by norovirus infection.
moreShow HLVX Financials
Recent trades of HLVX by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by HLVX's directors and management
Government lobbying spending instances
New patents grants
Federal grants, loans, and purchases
Followers on HLVX's company Twitter account
Number of mentions of HLVX in WallStreetBets Daily Discussion
Recent insights relating to HLVX
Recent picks made for HLVX stock on CNBC
ETFs with the largest estimated holdings in HLVX
Flights by private jets registered to HLVX